1.Differences in Various Detection Methods for Residual Solvents in Cosmetics and Drugs
China Pharmacist 2017;20(9):1643-1648
Objective:To summarize the differences and similarities in the detection methods for residual solvents between Safety and Technical Standards for Cosmetics 2015 edition and Chinese Pharmacopoeia 2015 edition so as to provide reference for the improve-ment of the detection methods for residual solvents in Safety and Technical Standards for Cosmetics. Methods:The type and limitations of residual solvents and the characteristics of the test methods for residual solvents between Safety and Technical Standards for Cosmetics 2015 edition and Chinese Pharmacopoeia 2015 edition were compared and analyzed. Results: The detection methods for residual sol-vents in Chinese Pharmacopoeia were more detailed. The detection methods for residual solvents in Safety and Technical Standards for Cosmetics were general detection method, and the process could be applied in the detection of more solvents. Some detection methods were short of limitations. Conclusion:The control of residual solvents in cosmetics should be improved if the limitations table of the limiting used solvents is introduced into Safety and Technical Standards for Cosmetics referring to Chinese Pharmacopoeia and increase the types of residual solvents detected by the general methods.
2.A Comparison of Curative Effect of Cinepazide Maleate and Nimodipine in Patients with Hypertensive Cerebral Hemorrhage after Microtraumatic Craniopuncture
Xiao HAO ; Xueliang LI ; Liqiang YUE ; Jiamin GAO
Chinese Journal of Primary Medicine and Pharmacy 2011;18(7):916-917
Objective To observe the effects of cinepazide maleate and nimodipine in improving the neurological function in patients with hypertensive cerebral hemorrhage after microtraumatic craniopuncture.Methods Seventy-eight patients with hypertensive cerebral hemorrhage were randomly divided into 2 groups,cinepazide maleate group (39 patients)and nimodipine group(39 patients).After 3 days operated with the microtraumatic craniopuncture,cinepazide maleate group used the amount 160mg cinepazide maleate mixed with sodium chloride injection(500ml,concentration 0.9%),and the nimodipine group uesd nimodipine(4mg)mixed with the same injection.Both the patients of the 2 groups were given intravenous drip once a day,then after continuous 14 days,the general information and the improvement of nerve were observeed.Results The total improvement rate and the improvement rate of nervous symptom was 87.2%and 61.5%respectively,in comparison,the nimodipine group was 64.1%and 39.9%.Conclusion Cinepazide maleate was better than nimodipine in improving chnical symptoms and the neurological deficit of the patients with hypertensive cerebral hemorrhage after microtraumatic craniopuncture.
3.Setup error of Orfit versus vacuum bag in radiotherapy for cervical cancer
Lijuan GAO ; Jiamin HUANG ; Jun HUANG ; Jianxin SU ; Yuqi WU ; Chengguang LIN
Chinese Journal of Radiation Oncology 2017;26(9):1080-1083
Objective To compare the setup errors of the negative pressure vacuum air cushion (vacuum bag) and the Orfit body foam fixator (Orfit frame) in radiotherapy for cervical cancer.Methods A total of 40 patients receiving three-dimensional radiotherapy for cervical cancer were enrolled in this study and equally and randomly divided into vacuum bag group and Orfit frame group.And the two groups were divided into Orfit-1 group, Orfit-2 group, vacuum-1 group, and vacuum-2 group according to the treatment course.The Orfit-1 group and vacuum-1 group were the data in the first 12 treatments, while the Orfit-2 group and vacuum-2 group were the data in the following 13 treatments.A cone-beam computed tomography scan was performed before each treatment to analyze setup error and then the body position was corrected to start the treatment.Comparison of continuous data between groups was made by paired t-test, while comparison of categorical data was made by chi-square test.Results There was a significant difference in the setup error in y-axis direction between the Orfit-1 group and the Orfit-2 group (P=0.003) and the setup error in r-axis direction between the vacuum-1 group and the vacuum-2 group (P=0.013).There were no significant differences in the setup errors in four directions (x-axis, y-axis, z-axis, and r-axis) between the Orfit-1 group and the vacuum-1 group (P>0.05).There were significant differences in the setup errors in y-axis and z-axis directions between the Orfit-2 group and the vacuum-2 group (P=0.007;P=0.001).Conclusions The Orfit frame and the vacuum bag have their own advantages and disadvantages in the fixation of body position in radiotherapy for cervical cancer.The setup error can be improved by long vacuum bags, ultrasound bladder capacity scanner, image-guided radiotherapy, or sectional radiotherapy plan.
4.Preparation and characterization of a mouse anti-human CD40 mutant monoclonal antibody
Shudan ZHENG ; Hongbing MA ; Chao GAO ; Jiamin WANG ; Jing SUN ; Xianfu LUO ; Xueguang ZHANG
Journal of Cellular and Molecular Immunology 2009;25(10):910-913
AIM: To prepare and characterize a mouse anti-human CD40 mutant monoclonal mAb. METHODS: Female BALB/c mice of 6-8 weeks old were immunized with CD40 mutant transfectant (L929-CD40mu) as immunogen. The spleen B cells of the mice were fused with Sp2/0 myeloma cells. The hybridoma cells were screened with CD40 mutant transfectant (L929-CD40mu) by FCM. Faststrip analysis was performed to identify Ig subclass of this mAb. The epitope recognized by this mAb was detected by Bio-5C11 competitive assay. Western blot technique was adopted to identify the mAb. The proliferation of tumor cells in vitro was analyzed by MTT assay and apoptosis of tumor cells in vitro was analyzed by PI-annexin V assay. RESULTS: One hybridoma cell line named 10C5 was obtained, which had the property of secreting anti-human CD40 mutant monoclonal antibody continuously and steadily. This mAb specifically recognized human CD40 mutant molecule and induced the apoptosis of tumor cells in vitro. CONCLUSION: One hybridoma cell line which can secret a mouse anti-human CD40 mutant mAb has been prepared successfully. This mAb can inhibit the growth of tumor cells expressing CD40 mutant and induce their apoptosis in vitro.
5.Uncertainty Evaluation for the Determination of Dexamethasone in Cosmetics by Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry
Jiamin GAO ; Jin CAO ; Hong DING
China Pharmacist 2018;21(3):539-542,546
Objective:To evaluate the measurement uncertainty in the determination of dexamethasone in cosmetics by ultra per-formance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Methods: The uncertainty caused by various factors in the whole determination process was analyzed,including weighing,standard solution preparation,calibration fitting,extraction and de-termination. Results:The combined uncertainty in the determination of dexamethasone in cosmetics was 0.75 μg·g-1and the ex-panded uncertainty was 1.5 μg·g-1. The content of dexamethasone in cosmetics was(20.4 ± 1.5) μg·g-1(k=2,confidence inter-val p=95%). Conclusion:The uncertainty of the method is mainly caused by standard solution preparation and calibration fitting.
6.Clinical application status of T cell immunoglobulin and mucin domain-containing protein 3 and its monoclonal antibody in tumor
Shuyue GAO ; Feiyu ZHAO ; Runjia FAN ; Jiamin CHENG ; Niansong QIAN
Journal of Clinical Medicine in Practice 2023;27(24):132-137
T cell immunoglobulin and mucin domain-containing protein 3(Tim-3)is a member of the Tim family,which is widely expressed on the surface of various cells and can be involved in the occurrence and development of diseases such as autoimmune,infection and cancer.Clinical trials have found that a combination of blocking Tim-3 and programmed cell death 1(PD-1)can improve the anti-cancer immune response and regression of tumors in patients with advanced cancer.This arti-cle reviewed the basic biological structure of Tim-3,corresponding ligand and its role in tumor micro-environment,and summarized the ongoing clinical trials of TIM-3.These data suggested that Tim-3 could be used as a potentially significant checkpoint receptor for future anti-tumor therapy,and sum-marized the ongoing clinical trials of drugs,indicating that Tim-3 can be used as a potential check-point receptor for future anti-tumor therapy.
7.Clinical application status of T cell immunoglobulin and mucin domain-containing protein 3 and its monoclonal antibody in tumor
Shuyue GAO ; Feiyu ZHAO ; Runjia FAN ; Jiamin CHENG ; Niansong QIAN
Journal of Clinical Medicine in Practice 2023;27(24):132-137
T cell immunoglobulin and mucin domain-containing protein 3(Tim-3)is a member of the Tim family,which is widely expressed on the surface of various cells and can be involved in the occurrence and development of diseases such as autoimmune,infection and cancer.Clinical trials have found that a combination of blocking Tim-3 and programmed cell death 1(PD-1)can improve the anti-cancer immune response and regression of tumors in patients with advanced cancer.This arti-cle reviewed the basic biological structure of Tim-3,corresponding ligand and its role in tumor micro-environment,and summarized the ongoing clinical trials of TIM-3.These data suggested that Tim-3 could be used as a potentially significant checkpoint receptor for future anti-tumor therapy,and sum-marized the ongoing clinical trials of drugs,indicating that Tim-3 can be used as a potential check-point receptor for future anti-tumor therapy.
8.Role and mechanism of Lycium barbarum polysaccharide combined with aerobic exercise in improving nonalcoholic steatohepatitis in rats
Jiamin MA ; Lulu GAO ; Mengwei ZHANG ; Qinghan GAO ; Xiujuan TAO ; Yanna FAN ; Jianjun YANG
Journal of Clinical Hepatology 2021;37(6):1348-1353
ObjectiveTo investigate the protective effect of Lycium barbarum polysaccharide (LBP) combined with aerobic exercise (AE) on the liver of rats with nonalcoholic steatohepatitis (NASH) induced by high-fat diet based on the p38 mitogen-activated protein kinase (p38 MAPK)-nuclear factor-κB (NF-κB) pathway. MethodsAfter 1 week of adaptive feeding, 45 Sprague-Dawley rats, aged 8 weeks, were randomly divided into control group (10 rats fed with normal diet) and high-fat group (35 rats fed with high-fat diet). At the end of week 28, the high-fat group was randomly divided into model group, LBP group, AE group, and LBP+AE group, with 8 rats in each group, and intervention was performed for 10 weeks. At the end of the experiment, fasting blood glucose was measure for all rats, and serum samples, liver tissue, and visceral fat were collected. Biochemical kits were used to measure the serum levels of triglyceride (TG), total cholesterol (TC), alanine aminotransferase (ALT), and aspartate aminotransferase (AST); ELISA kits were used to measure the serum levels of fasting insulin (FINS), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemotactic protein-1 (MCP-1); quantitative real-time PCR and Western blot were used to measure the mRNA and protein expression levels of Toll-like receptor 4 (TLR4), p38 MAPK, and NF-κB in liver tissue. A one-way analysis of variance was used for comparison of continuous data between multiple groups, and the least significant difference t-test was used for further comparison between two groups. ResultsCompared with the control group, the model group had significant increases in TG, TC, AST, ALT, FINS, and homeostasis model assessment of insulin resistance (HOMA-IR) (all P <0.05), a tendency of increases in the serum levels of the inflammatory factors MCP-1, TNF-α, and IL-6 (all P <0.05), and significant increases in the mRNA and protein expression levels of TLR4, p38 MAPK, and NF-κB in liver tissue (all P <0.05). Compared with the model group, each intervention group had significant reductions in TG, TC, AST, ALT, FINS, and HOMA-IR (all P <0.05), a tendency of reductions in the serum levels of the inflammatory factors MCP-1, TNF-α, and IL-6 (all P <0.05), and significant reductions in the mRNA and protein expression levels of TLR4, p38 MAPK, and NF-κB (all P <0.05). Compared with LBP group, the LBP+AE group had significant reductions in TG, ALT, FINS, HOMA-IR, MCP-1, the mRNA expression level of TLR4, protein expression levels of p38 MAPK and NF-κB(all P<0.05). Compared with Ae group, the LBP+AE group had significant reductions in FINS, HOMA-IR, IL-6, MCP-1, the mRNA expression level of TLR4 (all P<0.05). ConclusionLBP combined with AE may improve inflammation in NASH rats by regulating the p38 MAPK/NF-κB pathway.
9.Brusatol Suppresses Proliferation of Human Gastric Cancer HGC-27 Cells Through Inducing Ferroptosis via Nrf2/HO-1 Pathway
Wei GAO ; Hairong ZENG ; Jiamin LE
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(2):81-87
ObjectiveTo study effect of brusatol (BR) on proliferation of human gastric cancer HGC-27 cells and its mechanism. MethodCell counting kit-8 (CCK-8) was used to detect the survival rate of HGC-27 cells at different concentrations of BR. HGC-27 cells were treated with BR (7.5, 15, 30 μmol·L-1) for 24 h, and then the cell clone formation was analyzed. 2,7-Dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescent probe and lipid peroxidation sensor (C11-BODIPY) were employed to detect the levels of intracellular reactive oxygen species (ROS) and lipid peroxidation, respectively. Real-time polymerase chain reaction (Real-time PCR) and Western blot were performed to detect the messenger ribonucleic acid (mRNA) and protein expressions of solute carrier family 7 member 11 (SLC7A11), glutathione peroxidase 4 (GPX4), solute carrier family 40 member 1 (SLC40A1), transferrin, nuclear factor E2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1), respectively. ResultThe survival rate of HGC-27 cells was decreased with the increase of BR concentration, and the IC50 was 15.34 μmol·L-1. Compared with the conditions in blank group, the cell clone formation of BR (7.5, 15, 30 μmol·L-1) groups was inhibited in a dose-dependent manner (P<0.05,P<0.01), while the levels of intracellular ROS and lipid peroxidation, iron concentration, and lactic dehydrogenase (LDH) leakage were increased in a dose-dependent manner (P<0.05,P<0.01). Compared with the blank group, the BR (15, 30 μmol·L-1) groups lowered the mRNA and protein expressions of SLC7A11, GPX4, SLC40A1, Nrf2 and HO-1, while elevated the mRNA and protein expression of TRF in a dose-dependent manner (P<0.05,P<0.01). ConclusionBR suppressed the proliferation of HGC-27 cells through inducing ferroptosis via inhibiting Nrf2/HO-1 pathway.
10.Applications of microsimulation model for cost-effectiveness analysis on screening in epidemiology
Qiuping LIU ; Jiamin WANG ; Chao GONG ; Pei GAO ; Xun TANG ; Yonghua HU
Chinese Journal of Epidemiology 2022;43(6):931-937
Microsimulation model simulates individuals and estimates transition probabilities within the population using individual participant data. This approach could deal with the heterogeneous characteristics among the people or personal history of diseases and may be relevant in addressing cost-effectiveness problems of screening for complex conditions in epidemiology. This paper introduces the general principles, basic steps involved in implementation, analytic methods, and other related issues of the microsimulation model. Based on a practical research case of estimating the cost-effectiveness of microalbuminuria screening for chronic kidney disease in the United States, critical points in applications of the microsimulation model for cost-effectiveness analysis of screening were discussed in detail, including model development, model analysis, and the interpretation of the results. The microsimulation model considers the dynamic nature of complex diseases by estimating a broad range of individual characteristics and increasingly used to provide insights into complex problems that the Markov model does not efficiently address. For better supporting evidence-informed decision-making in public health, future studies should be aware of the accuracy of parameters in the decision-analytic model and the transparency of the models and results, as well as complying with the relevant reporting standards.